Freedman NM - Search Results

1

Potential (18)F-labeled biomarkers for epidermal growth factor receptor tyrosine kinase.

Bonasera TA, Ortu G, Rozen Y, Krais R, Freedman NM, Chisin R, Gazit A, Levitzki A, Mishani E. Bonasera TA, et al. Among authors: freedman nm. Nucl Med Biol. 2001 May;28(4):359-74. doi: 10.1016/s0969-8051(01)00200-1. Nucl Med Biol. 2001. PMID: 11395308

2

Labeled EGFr-TK irreversible inhibitor (ML03): in vitro and in vivo properties, potential as PET biomarker for cancer and feasibility as anticancer drug.

Ortu G, Ben-David I, Rozen Y, Freedman NM, Chisin R, Levitzki A, Mishani E. Ortu G, et al. Among authors: freedman nm. Int J Cancer. 2002 Oct 1;101(4):360-70. doi: 10.1002/ijc.10619. Int J Cancer. 2002. PMID: 12209961

3

Ga-68 DOTA-NOC uptake in the pancreas: pathological and physiological patterns.

Krausz Y, Rubinstein R, Appelbaum L, Mishani E, Orevi M, Fraenkel M, Tshori S, Glaser B, Bocher M, Salmon A, Chisin R, Gross DJ, Freedman N. Krausz Y, et al. Clin Nucl Med. 2012 Jan;37(1):57-62. doi: 10.1097/RLU.0b013e3182393404. Clin Nucl Med. 2012. PMID: 22157030

4

11C-acetate PET/CT in bladder urothelial carcinoma: intraindividual comparison with 11C-choline.

Orevi M, Klein M, Mishani E, Chisin R, Freedman N, Gofrit ON. Orevi M, et al. Clin Nucl Med. 2012 Apr;37(4):e67-72. doi: 10.1097/RLU.0b013e31824786e7. Clin Nucl Med. 2012. PMID: 22391726

5

In vivo measurement of brain monoamine oxidase B occupancy by rasagiline, using (11)C-l-deprenyl and PET.

Freedman NM, Mishani E, Krausz Y, Weininger J, Lester H, Blaugrund E, Ehrlich D, Chisin R. Freedman NM, et al. J Nucl Med. 2005 Oct;46(10):1618-24. J Nucl Med. 2005. PMID: 16204711 Free article.

6

Novel and simple carbon-11-labeled ammonium salts as PET agents for myocardial perfusion imaging.

Ilovich O, Billauer H, Dotan S, Freedman NM, Bocher M, Mishani E. Ilovich O, et al. Among authors: freedman nm. Mol Imaging Biol. 2011 Feb;13(1):128-39. doi: 10.1007/s11307-010-0336-7. Mol Imaging Biol. 2011. PMID: 20480244

7

SPECT attenuation artifacts in normal and overweight persons: insights from a retrospective comparison of Rb-82 positron emission tomography and TI-201 SPECT myocardial perfusion imaging.

Freedman N, Schechter D, Klein M, Marciano R, Rozenman Y, Chisin R. Freedman N, et al. Clin Nucl Med. 2000 Dec;25(12):1019-23. doi: 10.1097/00003072-200012000-00014. Clin Nucl Med. 2000. PMID: 11129138

8

Localization of parathyroid adenoma by ¹¹C-choline PET/CT: preliminary results.

Orevi M, Freedman N, Mishani E, Bocher M, Jacobson O, Krausz Y. Orevi M, et al. Clin Nucl Med. 2014 Dec;39(12):1033-8. doi: 10.1097/RLU.0000000000000607. Clin Nucl Med. 2014. PMID: 25290292 Clinical Trial.

9

Contribution of whole body F-18-FDG-PET and lymphoscintigraphy to the assessment of regional and distant metastases in cutaneous malignant melanoma. A pilot study.

Klein M, Freedman N, Lotem M, Marciano R, Moshe S, Gimon Z, Chisin R. Klein M, et al. Nuklearmedizin. 2000;39(3):56-61. Nuklearmedizin. 2000. PMID: 10834191

10

Regional cerebral blood flow in patients with mild hypothyroidism.

Krausz Y, Freedman N, Lester H, Newman JP, Barkai G, Bocher M, Chisin R, Bonne O. Krausz Y, et al. J Nucl Med. 2004 Oct;45(10):1712-5. J Nucl Med. 2004. PMID: 15471838 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters